Depakote Lawsuit Settled For $9.5 Million


Depakote manufacturer Abbott Laboratories has agreed to a $9.5 million settlement with the state of Louisiana over allegations of Medicaid fraud.

According to the Washington Examiner, the state filed a lawsuit in 2011 against Abbott, saying it mis-branded the anti-epileptic medication and promoted the drug to control agitation and aggression in elderly dementia patients without approval from the U.S. Food and Drug Administration.

Depacon, Depakote, Depakote CP, Depakote ER, Depakene and Stavzor are very powerful drugs that have been linked to health issues in children when taken by pregnant mothers. If you used Depakote during pregnancy, and your child developed a physical birth defect or has suffered from cognitive problems, contact the Depakote attorneys of ZKB Law.

Zoll, Kranz & Borgess, LLC – Defective Medical Drug and Device Lawyers